Kappa & Lambda Free Light Chain Test – Overview

What is the Kappa & Lambda Free Light Chain Test?

The Kappa and Lambda Free Light Chain (FLC) test measures the levels of free light chains in the blood. Light chains are components of antibodies produced by plasma cells. Normally, they exist in a balanced ratio, but an abnormal increase may indicate plasma cell disorders, such as multiple myeloma or AL amyloidosis.

📌 This test helps diagnose and monitor multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), and other plasma cell disorders.

---

1. Why is the Kappa & Lambda Free Light Chain Test Done?

✅ To diagnose and monitor multiple myeloma and other plasma cell disorders
✅ To differentiate between polyclonal and monoclonal gammopathies
✅ To detect AL amyloidosis (light-chain deposition disease)
✅ To monitor response to treatment in patients with known plasma cell disorders

📌 This test is often done alongside serum protein electrophoresis (SPEP) and immunofixation electrophoresis (IFE).

---

2. Test Procedure

📌 Sample Collection

• Blood sample drawn from a vein
• No fasting required

🧪 Testing Method

• Immunoassay (to measure Kappa and Lambda light chain levels)
• Serum Protein Electrophoresis (SPEP) & Immunofixation (IFE) (to identify monoclonal proteins)

📌 Urine tests (Urine FLC or Bence-Jones Protein test) may also be performed to detect light chains in urine.

---

3. Normal & Abnormal Light Chain Levels

📌 Abnormal kappa/lambda ratios suggest plasma cell disorders.

---

4. Interpretation of Abnormal Results

🚩 High Kappa and/or Lambda Light Chains

• Multiple Myeloma (MM) – Monoclonal proliferation of plasma cells
• AL Amyloidosis – Light-chain deposition causing organ damage
• Monoclonal Gammopathy of Undetermined Significance (MGUS) – Precursor to myeloma
• Light Chain Myeloma – Only light chains (not complete immunoglobulins) are produced
• Chronic Kidney Disease (CKD) – Decreased clearance of light chains

🚩 Abnormal Kappa/Lambda Ratio

• Kappa/Lambda > 1.65 → Suggests excess kappa light chains (e.g., kappa-type myeloma)
• Kappa/Lambda < 0.26 → Suggests excess lambda light chains (e.g., lambda-type myeloma)

📌 A very high kappa or lambda light chain level (>100 mg/L) is highly suggestive of a plasma cell disorder.

---

5. Clinical Implications

✔️ If Free Light Chains are Elevated:

• Additional tests: Serum Protein Electrophoresis (SPEP), Urine Protein Electrophoresis (UPEP), Immunofixation Electrophoresis (IFE), Bone Marrow Biopsy
• Consider multiple myeloma, MGUS, or amyloidosis

✔️ If Free Light Chains are Normal:

• No evidence of a monoclonal plasma cell disorder

📌 Serial monitoring is required in diagnosed cases of multiple myeloma or amyloidosis.

---

Conclusion

The Kappa & Lambda Free Light Chain Test is essential for diagnosing and monitoring plasma cell disorders, such as multiple myeloma and AL amyloidosis. Abnormal results require further testing, including SPEP, IFE, and bone marrow biopsy, to confirm the diagnosis.